BES_Mark.jpg
AXSOME ALERT: Bragar Eagel & Squire, P.C. is Investigating Axsome Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 10, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Aug. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Axsome Therapeutics, Inc....
BES_Mark.jpg
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 09, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Masimo Corporation...
BES_Mark.jpg
LULULEMON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lululemon Athletica Inc. and Encourages Investors to Contact the Firm
August 09, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against...
BES_Mark.jpg
SONDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Sonder Holdings Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 09, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sonder Holdings Inc....
BES_Mark.jpg
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 09, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Tandem Diabetes Care, Inc....
BES_Mark.jpg
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 09, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against QuidelOrtho Corporation...
BES_Mark.jpg
XPEL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against XPEL, Inc. and Encourages Investors to Contact the Firm
August 09, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against XPEL,...
BES_Mark.jpg
MAISON ALERT: Bragar Eagel & Squire, P.C. is Investigating Maison Solutions Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 09, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Maison Solutions Inc....
BES_Mark.jpg
NBH ALERT: Bragar Eagel & Squire, P.C. is Investigating Next Bridge Hydrocarbons, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 09, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Next Bridge Hydrocarbons,...
Tevogen Logo Notified.png
Tevogen Bio’s Founding CEO, Ryan Saadi, Expresses Conviction in Company’s Growth Strategy and Reaffirms Newly Effective Form S-1 Does Not Relate to Previously Undisclosed New Issuance of Dilutive Securities
August 09, 2024 11:00 ET | Tevogen Bio Inc
Tevogen Bio reaffirms that the registration statement does not relate to any previously undisclosed new issuances of dilutive securities.